MAPT and Alzheimer disease: Our study demonstrates that hippocampal AAV-NF-α1/CPE treatment rescues neurodegeneration, cognitive dysfunction, tau hyperphosphorylation and elevated amyloid precursor protein (APP)/Aβ42 expression in male 3xTg-AD mice.